Beijing CAS Microneedle Technology, Ltd. was established in May 2018. It is a technology achievement transformation enterprise founded by researcher Gao Yunhua and her scientific research team. The company focuses on the research and development of polymer microneedle technology, as well as the production and sales of related products, aiming to provide cutting-edge transdermal drug delivery solutions for the pharmaceutical and medical beauty industries. Beijing CAS Microneedle possesses independent intellectual property rights across the entire microneedle drug delivery technology industry chain and has successfully applied for more than 60 domestic and international patents. From the initial design of microneedles to the production and manufacturing of molds, to the development of drug formulations, large-scale production, and product packaging, the company is equipped with a complete GMP automated production line with an annual capacity of up to 150 million patches. It is one of the world’s largest production bases for dissolving beauty patches and can provide diversified services such as CRO, CMO, CDMO, and OEM to customers in the pharmaceutical, health, and beauty skincare fields both domestically and internationally. Currently, in the cosmetics field, the company owns several brands derived from microneedle technology, such as Microacu and Casma; in the medical device sector, it has successfully obtained China’s first Class II medical device registration certificate and Class II medical device production license. We welcome industry partners to come and exchange ideas and collaborate!
